Gyre Therapeutics, Inc.
GYRE
$7.64
$0.060.79%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 139.32% | 116.59% | -19.97% | -20.41% | 13.20% |
| Total Receivables | 29.01% | 27.37% | 34.48% | 73.13% | -- |
| Inventory | 38.80% | 57.25% | 59.51% | 48.03% | -- |
| Prepaid Expenses | 173.36% | 134.26% | 355.92% | -23.14% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 37.42% | -- |
| Total Current Assets | 79.85% | 70.57% | 9.13% | 13.22% | -- |
|
|
|||||
| Total Current Assets | 79.85% | 70.57% | 9.13% | 13.22% | -- |
| Net Property, Plant & Equipment | -5.74% | -3.37% | 5.00% | 8.08% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 191.46% | 200.73% | 203.28% | 0.41% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -16.30% | -10.92% | -7.64% | -16.93% | -- |
| Total Assets | 27.26% | 26.23% | 6.38% | 7.61% | -- |
|
|
|||||
| Total Accounts Payable | 83.50% | -73.80% | -63.03% | -69.58% | -- |
| Total Accrued Expenses | 15.92% | 39.65% | -1.54% | -11.91% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -9.80% | -5.61% | 705.00% | 239.52% | -- |
| Total Finance Division Other Current Liabilities | -5.16% | -36.77% | -9.03% | 5.28% | -- |
| Total Other Current Liabilities | -5.16% | -36.77% | -9.03% | 5.28% | -- |
| Total Current Liabilities | 8.13% | 8.64% | -2.54% | -2.65% | -- |
|
|
|||||
| Total Current Liabilities | 8.13% | 8.64% | -2.54% | -2.65% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -51.04% | -40.56% | 345.71% | 344.72% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -49.61% | -48.54% | -57.90% | -62.94% | -- |
| Total Liabilities | -17.92% | -15.88% | -23.32% | -29.06% | -- |
|
|
|||||
| Common Stock & APIC | 24.44% | 20.78% | 3.74% | 99.65% | -- |
| Retained Earnings | 9.47% | 5.83% | 9.68% | 14.66% | -- |
| Treasury Stock & Other | -79.70% | -13.78% | -43.20% | -57.97% | -- |
| Total Common Equity | 61.32% | 52.48% | 20.27% | 500.04% | -35.27% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 61.32% | 52.48% | 20.27% | 500.04% | -35.27% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 0.57% | 13.40% | 12.60% | 17.82% | -- |
| Total Equity | 39.54% | 38.67% | 17.50% | 25.39% | 0.90% |
|
|
|||||